No Evidence that 2D:4D is Related to the Number of CAG Repeats in the Androgen Receptor Gene by Honekopp, Johannes
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ORIGINAL RESEARCH ARTICLE
published: 05 December 2013
doi: 10.3389/fendo.2013.00185
No evidence that 2D:4D is related to the number of CAG
repeats in the androgen receptor gene
Johannes Hönekopp*
Department of Psychology, Northumbria University, Newcastle upon Tyne, UK
Edited by:
Rebecca Christine Knickmeyer,
University of North Carolina at Chapel
Hill, USA
Reviewed by:
Eli Hershkovitz, Soroka Medical
University Center, Israel
Britton Trabert, National Institutes of
Health, USA
*Correspondence:
Johannes Hönekopp, Department of
Psychology, Northumbria University,
Newcastle upon Tyne NE1 8ST, UK
e-mail: johannes.honekopp@
unn.ac.uk
The length ratio of the second to the fourth digit (2D:4D) is a putative marker of prenatal
testosterone (T) effects. The number of CAG repeats (CAGn) in the AR gene is negatively
correlated with T sensitivity in vitro. Results regarding the relationship between 2D:4D
and CAGn are mixed but have featured prominently in arguments for and against the
validity of 2D:4D. Here, I present random-effects meta-analyses on 14 relevant samples
with altogether 1904 subjects. Results were homogeneous across studies. Even liberal
estimates (upper limit of the 95% CI) were close to zero and therefore suggested no
substantial relationship of CAGn with either right-hand 2D:4D, left-hand 2D:4D, or the dif-
ference between the two. However, closer analysis of the effects of CAGn onT dependent
gene activation in vitro and of relationships between CAGn and T dependent phenotypic
characteristics suggest that normal variability of CAGn has mostly no, very small, or incon-
sistent effects.Therefore, the lack of a clear association between CAGn and 2D:4D has no
negative implications for the latter’s validity as a marker of prenatal T effects.
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INTRODUCTION
In contrast to circulating testosterone (T), perinatal T has long-
lasting,“organizational”effects in many species, including humans
(1). In the latter, T levels are particularly relevant during the sec-
ond trimester, but their effects are notoriously difficult to study
(2). However, 2D:4D (i.e., the length of the second digit divided
by the length of the fourth digit) seems to track prenatal steroid
effects (3), thereby providing an easily accessible, though proba-
bly noisy (4–6) index of individuals’ hormonal past. In short, this
is evidenced by experiments in mice [e.g., Ref. (7)]; correlations
between steroid levels in amniotic fluid and 2D:4D at age 2 years
(8); masculinized (i.e., lowered) 2D:4D in females exposed to high
prenatal T levels caused by congenital adrenal hyperplasia [d ≈ 0.8;
Ref. (9)]; and feminized 2D:4D in (i) genetic males with complete
androgen insensitivity syndrome [d ≈ 0.5; Ref. (4)] and (ii) in
males with Klinefelter’s syndrome [d ≈ 0.8; Ref. (10)], a condition
associated with low T levels throughout development. The sex dif-
ference in 2D:4D seen in adults [d ≈ 0.4; Ref. (9)] is established
in utero [d ≈ 0.6; Ref. (11, 12)]; individual 2D:4D scores show sta-
bility during development, including puberty [e.g., Ref. (13)] and
are unrelated to baseline circulating T levels in adults (14, 15).
Testosterone effects depend on a structure called androgen
receptor (AR), which comes in different variants, some of them
leading to stronger T effects than others. The relationship between
these AR variants and 2D:4D has received considerable attention,
based on the notion that if 2D:4D reflects prenatal T effects and
if AR variants moderate T effects, AR variants should show sys-
tematic relationships with 2D:4D [e.g., Ref. (16, 17)]. The current
paper seeks to describe this relationship. However, before this is
addressed further, it is necessary to look at the link between the
AR and T effects in greater detail.
Testosterone regulates the transcription of genes, and this
depends on the AR. In the cytoplasm, the AR is bound to heat-
shock proteins and therefore inactive. When binding with T or
dihydrotestosterone, the AR sheds its heat-shock proteins, changes
into an active shape and migrates to the cell nucleus. There, it con-
nects with coactivators and another AR and then binds in this
dimerized form to specific sites in the DNA where it regulates the
transcription of target genes (18, 19).
The AR is produced by the AR gene, which is located on
the X-chromosome. On exon 1, this gene repeats the nucleotide
sequence CAG; the number of these repeats (CAGn) varies inter-
individually in length and codes for the length of a polyglutamine
stretch on the N-terminal domain of the AR. Most humans have
CAGn between 15 and 30, the average is about 22 with a standard
deviation of about 3.5 (20). Experiments in vitro demonstrated
that longer polyglutamine stretches make the AR less effective,
resulting in less AR-regulated genetic activity [e.g., Ref. (21–23)].
In such studies, cell lines from either monkey kidneys or human
prostate cancer are transfected with AR gene variants that differ
in CAGn. Subsequent activity of a target gene is then measured
in the presence and absence of androgen. How strong is the effect
of CAGn on target gene activity? I used figures in relevant reports
(20–26) to calculate regression slopes that reflect by what propor-
tion target gene activity drops for each additional CAG repeat (cf.
Figure 1); activity at “normal” CAGn (around 20) served as the
100% baseline in each case. Where non-linear effects occurred at
CAGn outside the normal human range (20, 25), I restricted the
computation of the regression slope to the CAGn range that pro-
duced a linear effect. Figure 1 illustrates this process based on a
fictitious in vitro study. As can be seen from Table 1, which pro-
vides an overview of the results, regression slopes averaged−2.3%
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FIGURE 1 | Fictitious example of in vitro study into the effect of CAGn
on target gene activity. Example for regression of the activity of a
testosterone regulated target gene on CAGn in in vitro studies (cf.Table 1).
ARs with CAGn of 0, 15, 18, 21, 24, or 27 are used either with testosterone
(gray bars) or without testosterone (black bars). Target gene activity
observed at CAGn most typical in humans (21) is set to 100%.Then the
regression slope (dashed line, −2.3%) is calculated to describe target gene
activity as a function of CAGn. In cases like the present, where CAGn
outside the human range produce a deviation from linearity (here 0 CAGn),
the regression slope was calculated only for those CAGn that showed a
linear function.
Table 1 | Change in androgen driven target gene activity per additional
CAG repeat in the AR gene in in vitro studies.
Study Cell type CAGn range
tested
Change
(%)
Beilin et al. (21) Monkey kidney 15–31 −2.8
Callewaert et al. (24) Monkey kidney 0–9 −3.9
Chamberlain et al. (22) Monkey kidney 25–77 −0.7
Kazemi-Esfarjani et al. (26) Monkey kidney 0–50 −1.9
Beilin et al. (21) Prostate cancer 15–31 −1.4
Buchanan et al. (20) Prostate cancer 16–35 −1.8
Ding et al. (23) Prostate cancer 14–25 −1.0
Irvine et al. (25) Prostate cancer 9–42 −0.7
for cell lines from monkey kidneys and−1.2% for prostate cancer
cell lines.
In short then, high CAGn is associated with low androgen sen-
sitivity in vitro; hence, a positive relationship between CAGn and
2D:4D might be expected. The first report of such a correlation
(17) became one of the most frequently cited papers in the 2D:4D
literature; however, later studies showed an inconsistent picture
with a mixture of positive and negative findings [e.g., Ref. (27,
16)]. The relationship between CAGn and 2D:4D has often played
a prominent role in discussions of the validity of 2D:4D as a marker
of prenatal T effects. For example Breedlove (5) argued, “the
strongest evidence that androgens affect digit ratios is the report
(17) that normal polymorphism in the AR gene correlates with
digit ratios in men” (p. 4117); conversely, Hampson and Sankar
(16) concluded that their failure to find a positive relationship
between CAGn and 2D:4D “call[s] into question the widespread
assumption that small differences in the size of [. . .] [2D:4D] are
an accurate gage of relative differences across individuals in fetal
testosterone exposure” (p. 560).
This paper has two purposes. First, to clarify the relationship
between 2D:4D and CAGn; to this end, I present a meta-analysis
of the relevant literature. And second, to discuss in greater detail
the implications of this relationship for the validity of 2D:4D as a
marker of prenatal T effects.
MATERIALS AND METHODS
Studies were retrieved with the search terms 2D:4D OR digit ratio
in conjunction with CAG OR AR in the topics field in ISI Web of
Science and in the MeSH Major Topic field in PubMed ; this resulted
in nine relevant studies from which 14 samples with 792 females
and 1331 males entered the analyses. For all samples, CAGn was
treated as a continuous measure and I report Pearson correla-
tions with 2D:4D in all cases. As females (but not males) have
two AR gene copies, either the shorter allele, the longer allele, or
the bi-allelic mean can be used. One report (28) reported all three
analyses (which led to very similar results), and I used the result for
the bi-allelic mean in the present analysis. For two other reports
that involved females (29, 30) it remained unclear on which of the
three measures their analysis was based.
In line with the approach in the primary studies, separate
meta-analyses were run for 2D:4Dr (right-hand 2D:4D), 2D:4Dl
(left-hand 2D:4D), and Dr-l (2D:4Dr× 2D:4Dl). One longitudi-
nal study (29) reported multiple results for each 2D:4D measure
and CAG repeats in the same sample. These were averaged so
that each sample contributed only one effect size in each meta-
analysis. The Knickmeyer samples and the Loehlin et al. (30)
study contained sib-pairs. Although this creates statistical depen-
dencies, the weighting of these samples in the analyses was not
corrected downwards, mostly because it did not matter, as I will
discuss later. Typically, samples showed little or no ethnic hetero-
geneity; for one atypical study (31), results with ethnic group as
a covariate were used. Where relevant information was missing
in the publications, authors were contacted (cf. note in Table 1).
Random-effects meta-analyses were performed (32), which model
the population correlation as a random variable with mean ρ and
variance τ2. Due to chance effects in sampling, multiple stud-
ies into the same phenomenon are expected to produce different
results, resulting in variance of the correlations in primary studies.
If the observed variance exceeds the variance to be expected due
to random sampling, this suggests that primary studies differ in a
systematic fashion, i.e., that not all tap into the same population
correlation. E.g., the correlation between CAGn and 2D:4D might
differ for females and males, young and old, etc. τ2 reflects to what
extent the observed variance in correlations exceeds the variance
expected due to random sampling. The Q-statistic is used to test if
this excess variance deviates significantly from zero. In the results, I
report the standard deviation τ instead of the variance τ2 because
the former is easier to interpret. Analyses were carried out with
Comprehensive Meta-Analysis (2.2.064).
Frontiers in Endocrinology | Pediatric Endocrinology December 2013 | Volume 4 | Article 185 | 2
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hönekopp 2D:4D and CAG repeats in the AR gene
Table 2 | Primary studies investigating the relationship between 2D:4D and CAGn.
Study Country Age Sex CAGn N r
2D:4D RIGHT HAND
Manning et al. (17) England 32.6±14.2 M 21.4±2.3 50 0.29*
Butovskaya et al. (27)a Tanzania ≈34±13 M 22.5±2.2 107 0.135
Folland et al. (33) England 20.1±2.2 M 26±4 77 0.10
Loehlin et al. (30) Australia ≈14 F 218 0.08
Hurd et al. (31) Canada ≈19±2 M 155 0.05
Knickmeyer et al. (29)a USA/Asian ≈1 M/F 6 0.04
Zhang et al. (28) China 19.9±1.4 F 391 0.030
Mas et al. (34)a M 70 0.005
Zhang et al. (28) China 19.9±1.4 M 294 0.003
Knickmeyer et al. (29)a USA/Black ≈1 M/F 31 −0.01
Knickmeyer et al. (29)a USA/White ≈1 M/F ≈19.7±2.5 108 −0.04
Mas et al. (34)a Mb 63 −0.04
Loehlin et al. (30) Australia ≈14 M 22.1±3.1 182 −0.06
Hampson and Sankar (16) Canada 18.7±1.6 M 152 −0.085
2D:4D LEFT HAND
Folland et al. (33) England 20.1±2.2 M 26±4 77 0.2
Butovskaya et al. (27)a Tanzania ≈34±13 M 22.5±2.2 107 0.191*
Loehlin et al. (30) Australia ≈14 F 218 0.14*
Zhang et al. (28) China 19.9±1.4 M 294 0.016
Manning et al. (17) England 32.6±14.2 M 21.4±2.3 50 0.005
Mas et al. (34)a M 70 −0.014
Zhang et al. (28) China 19.9±1.4 F 391 −0.018
Knickmeyer et al. (29)a USA/White ≈1 M/F ≈19.7±2.5 111 −0.03
Hampson and Sankar (16) Canada 18.7±1.6 M 22.1±3.1 152 −0.063
Hurd et al. (31) Canada ≈19±2 M 153 −0.08
Knickmeyer et al. (29)a USA/Black ≈1 M/F 31 −0.08
Mas et al. (34)a Mb 63 −0.081
Loehlin et al. (30) Australia ≈14 M 181 −0.13
Knickmeyer et al. (29)a USA/Asian ≈1 M/F 6 −0.41
Dr−l
Knickmeyer et al. (29)a USA/Asian ≈1 M/F 6 0.41
Manning et al. (17) England 32.6±14.2 M 21.4±2.3 50 0.36***
Hurd et al. (31) Canada ≈19±2 M 153 0.14
Loehlin et al. (30) Australia ≈14 M 181 0.10
Knickmeyer et al. (29)a USA/Black ≈1 M/F 30 0.10
Zhang et al. (28) China 19.9±1.4 F 391 0.055
Knickmeyer et al. (29)a USA/White ≈1 M/F ≈19.7±2.5 105 0.04
Mas et al. (34)a M 70 −0.021
Zhang et al. (28) China 19.9±1.4 M 294 −0.022
Hampson and Sankar (16) Canada 18.7±1.6 M 22.1±3.1 152 −0.047
Mas et al. (34)a Mb 63 −0.057
Loehlin et al. (30) Australia ≈14 F 218 −0.06
Butovskaya et al. (27)a Tanzania ≈34±13 M 22.5±2.2 107 −0.080
Dr−l indicates right-hand 2D:4D minus left-hand 2D:4D.
aPlus personal communication.
bMale-to-female transsexuals.
*p<0.05. ***p<0.001.
RESULTS
The results for individual studies are listed in Table 2. The results
of the three meta-analyses are summarized in Table 3. As can
be seen from column ρ, estimates for all population correlations
were close to (and not significantly different from) zero, and all
upper limits of the 95% CI were r < 0.09. Estimates for random
variance around ρ were zero or small, and not statistically sig-
nificant. Therefore, no attempt was made to explain differences
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Table 3 | Results of meta-analyses for the relationship between CAGn
and 2D:4D.
Mean effect size Random variance
ρ Z p 95% CI
upper
bound
τ Q (df) p
ALL SAMPLES
2D:4D right hand 0.023 1 0.318 0.068 0 10.0(13) 0.696
2D:4D left hand 0.004 0.14 0.888 0.059 0.05 17.2(13) 0.188
Dr−l 0.027 1 0.320 0.081 0.04 14.5(12) 0.269
MALE SAMPLES ONLY
2D:4D right hand 0.018 0.58 0.564 0.080 0.03 8.8(8) 0.361
2D:4D left hand −0.005 0.13 0.896 0.070 0.06 11.9(8) 0.155
Dr−l 0.035 0.818 0.414 0.117 0.08 11.9(7) 0.103
Estimates for the population correlation ρ and the upper bound of the 95%
confidence interval are Pearson correlations.
across study results via meta-regression. Results remained basi-
cally unchanged when: the female and mixed-sex samples (k = 4)
were removed (cf. Table 3); when an unusual sample of male-
to-female transsexuals was removed (detailed results not shown
here); or when all of the previous were excluded from analysis
(detailed results not shown here).
DISCUSSION
Estimates for the population correlations between CAGn and
2D:4D were close to zero and not statistically significant, and even
a liberal viewpoint suggests that any relationship is at best very
small (largest upper limit for 95% CI in the full data set r = 0.08).
None or little (and statistically non-significant) random variance
was observed. Therefore, sampling error suffices to explain the
mixture of significant and non-significant findings and there is
no reason to assume that the former meaningfully differ from the
latter (35). As mentioned in the method section, the Loehlin et al.
(30) and the Knickmeyer et al. (29) samples contained numer-
ous sib-pairs, and this was not reflected in the weighting of these
samples in the current analyses. However, Table 1 shows that the
results for these samples were either close to the estimates for ρ
or else had very small sample sizes and therefore had little impact
on ρ estimates in the first place; consequently, somewhat reduced
weights for these samples would not have meaningfully altered the
outcome of any of the analyses or any conclusions drawn. This is
also illustrated by the result of the analysis that excluded mixed-sex
samples (i.e., the three Knickmeyer et al. (29) samples).
Overall, the evidence is quite clear then that 2D:4D and CAGn
show no substantial relationship. What does this mean for the
validity of 2D:4D as a marker of prenatal T effects? Several
authors argued that a relationship between CAGn and 2D:4D
is to be expected if the latter indeed reflects prenatal T effects
(5, 16, 17), the logic being that if variables A and B correlate,
and variables B and C do as well, then a correlation between A
and C should emerge. However, if rAB= 0.40 and rBC= 0.20, a
reasonable expectation for rAC is 0.08, and to differentiate this
empirically from the null hypothesis (r = 0.00) is difficult.
There is considerable indirect evidence that the link between
CAGn and T effects is weak, which is relevant in this context. First,
as discussed in the introduction, in vitro studies suggest that each
additional CAGn repeat lowers T effectiveness by about 2% (cf.
Table 1). Thus, a one standard deviation in CAGn [which is about
3.5, Ref. (20)] would result in a T effect change of only about
7% in vitro. Changes of this magnitude might only have a mod-
erate effect on 2D:4D: when Berenbaum et al. (4) looked at the
effect of a 100% change in T effects by comparing typically devel-
oping men with genetic males affected from complete androgen
insensitivity syndrome, the group difference in 2D:4D was about
d = 0.5, which is equivalent to a correlation of r = 0.2411. More-
over, in vitro studies might overestimate the effects of CAGn in vivo,
where lower androgen sensitivity due to higher CAGn appears to
be counterbalanced by higher circulating T levels, at least in adult
men (36, 37).
The second line of indirect evidence stems from relationships
between CAGn and other T dependent phenotypes. Androgenetic
alopecia (patterned hair loss from the scalp), male infertility, poly-
cystic ovary syndrome, and prostate cancer are conditions in the
genesis of which T is clearly implicated (38–41). Following the
same line of thought that led to the investigation of a potential link
between CAGn and 2D:4D (17), numerous studies looked into the
link between CAGn and these conditions. Recent meta-analyses of
these studies show that evidence for such a link is at best tentative
for prostate cancer and absent for the other three (41–43).
Androgens promote muscle growth and therefore affect FFM
(44). A similar picture emerges for the relationship between CAGn
and FFM. Pertinent studies (45–49) report results for 11 sam-
ples (median N = 115). Statistically significant results were only
obtained for the two male samples in Walsh et al. (49); in either
case a positive relationship between CAGn and FFM was observed,
which runs against expectations.
In a well-controlled intervention study by Woodhouse et al.
(44), 61 eugonadal young men received either 25, 50, 125, 300, or
600 mg/week T enanthate treatment for 20 weeks. FFM gains were
statistically modeled by T treatment, CAGn, age, initial strength,
and other variables. T treatment explained 64% of the variance
in FFM gain. The two next best predictors explained another 2
and 1% of variance, respectively, but CAGn was not among them.
When T treatment was excluded as a predictor, the best three-
variable model explained only 17% of the variance in FFM change,
and again CAGn was not among these predictors. In sum then the
results of this study do not suggest a sizable negative effect of CAGn
on FFM, which is in line with the correlational studies.
Inferences from androgenetic alopecia, male infertility, poly-
cystic ovary syndrome, prostate cancer, and FFM to 2D:4D are
tentative because the former concern adult phenotypes whereas
the latter is largely determined in utero (11, 12). Nonetheless,
these domains demonstrate that a T effect on a phenotype does
not necessarily mean that CAGn correlates with this phenotype.
Therefore, the lack of a substantial link between CAGn and 2D:4D
observed here does not necessarily implicate that 2D:4D is not
affected by prenatal T.
1This is because r =
√
d2
d2+4 .
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On the contrary, the absence of a strong relationship between
CAGn and 2D:4D makes the interpretation of 2D:4D findings
less ambiguous. If 2D:4D was substantially linked to CAGn, the
former might reflect AR effectiveness to a considerable degree.
Consequently, a given relationship between 2D:4D and the study
variable could reflect effects of circulating T, effects of prenatal T,
or both. In light of the nil or near-nil relationship between CAGn
and 2D:4D it seems less likely that observed correlations between
2D:4D and study variables reflect effects of circulating T instead
of prenatal T [see also Ref. (14)].
Hampson and Sankar (16) conceded that 2D:4D tracks large
prenatal T differences between groups (e.g., CAIS vs. typically
developing individuals) but argued that the lack of CAGn and
2D:4D demonstrates the latter’s inability to reflect finer prenatal
T differences within each sex. But I showed here that a sizable
relationship between CAGn and 2D:4D may not be expected even
when 2D:4D reflects prenatal T effects well. Further, strong rela-
tionships between 2D:4D and performance in sports have been
consistently shown (50–54), which also speaks against the idea that
2D:4D cannot explain within-sex differences. However, 2D:4D dif-
ferences tend to be moderate (d about 0.4–0.8) between groups
that differ strongly in prenatal T effects (4, 9, 10). This suggests
that other factors than prenatal steroids strongly affect 2D:4D
(55). Indeed, genetic factors unrelated to T have been implied
(56, 57). The use of 2D:4D as a marker for prenatal T effects
requires that the non-T variance in 2D:4D is not systematically
related to the study variable, and at present we know next to
nothing about this point. It would therefore be desirable to bet-
ter understand the non-T variance in 2D:4D, which might open
avenues for its statistical control. Further, a systematic review to
what extent 2D:4D and other methods that are less accessible
but also less controversial [e.g., Ref. (2)] lead to similar conclu-
sions about prenatal T effects on human behavior would appear
helpful.
CONCLUSION
A meta-analysis of the literature showed no evidence for a rela-
tionship between 2D:4D and CAGn. However, closer inspection
of the effects of CAGn on T dependent gene activation in vitro
and of relationships between CAGn and T dependent phenotypic
characteristics suggests that normal variability of CAGn has no,
very small, or inconsistent effects. Therefore, the observed lack of
an association between CAGn and 2D:4D does not undermine the
latter’s validity as an indicator of prenatal T effects.
ACKNOWLEDGMENTS
I would like to thank Frank Renkewitz for insightful discussions
of statistical matters and Tamsin Saxton for critical comments on
the manuscript.
REFERENCES
1. Hines M. Gender development and the human brain. Annu Rev Neurosci (2011)
34:69–88. doi:10.1146/annurev-neuro-061010-113654
2. Cohen-Bendahan CCC, van de Beek C, Berenbaum SA. Prenatal sex hormone
effects on child and adult sex-typed behavior: methods and findings. Neurosci
Biobehav Rev (2005) 29:353–84. doi:10.1016/j.neubiorev.2004.11.004
3. Manning JT. Resolving the role of prenatal sex steroids in the development of
digit ratio. Proc Natl Acad Sci U S A (2012) 108:16143–4. doi:10.1073/pnas.
1113312108
4. Berenbaum SA, Bryk KK, Nowak N, Quigley CA, Moffat S. Fingers as a
marker of prenatal androgen exposure. Endocrinology (2009) 150:4819–22.
doi:10.1210/en.2009-0774
5. Breedlove SM. Organizational hypothesis: instances of the fingerpost.
Endocrinology (2010) 151:4116–22. doi:10.1210/en.2010-0041
6. Dean A, Sharpe RM. Anogenital distance or digit length ratio as measures of
fetal androgen exposure: relationship to male reproductive development and its
disorders. J Clin Endocrinol Metab (2013) 98:2230–8. doi:10.1210/jc.2012-4057
7. Zheng Z, Cohn MJ. Developmental basis of sexually dimorphic digit ratios. Proc
Natl Acad Sci U S A (2011) 108:16289–94. doi:10.1073/pnas.1108312108
8. Lutchmaya S, Baron-Cohen S, Raggatt P, Knickmeyer R, Manning JT. 2nd to
4th digit ratios, fetal testosterone and estradiol. Early Hum Dev (2004) 77:23–8.
doi:10.1016/j.earlhumdev.2003.12.002
9. Hönekopp J, Watson S. Meta-Analysis of digit ratio 2D:4D shows greater sex
difference in the right hand. Am J Hum Biol (2010) 22:619–30. doi:10.1002/
ajhb.21054
10. Manning JT, Kilduff LP, Trivers R. Digit ratio (2D:4D) in Klinefelter’s syndrome.
Andrology (2013) 1:94–9. doi:10.1111/j.2047-2927.2012.00013.x
11. Galis F, Ten Broek CMA, Van Dongen S, Wijnaendts LCD. Sexual dimor-
phism in the prenatal digit ratio (2D:4D). Arch Sex Behav (2010) 39:57–62.
doi:10.1007/s10508-009-9485-7
12. Malas MA, Dogan S, Evcil EH, Desdicioglu K. Fetal development of the
hand, digits and digit ratio (2D:4D). Early Hum Dev (2006) 82:469–75.
doi:10.1016/j.earlhumdev.2005.12.002
13. Trivers R, Manning J, Jacobson A. A longitudinal study of digit ratio (2D:4D)
and other finger ratios in Jamaican children. Horm Behav (2006) 49:150–6.
doi:10.1016/j.yhbeh.2005.05.023
14. Hönekopp J, Bartholdt L, Beier L, Liebert A. Second to fourth digit length ratio
(2D:4D) and adult sex hormone levels: new data and a meta-analytic review. Psy-
choneuroendocrinology (2007) 32:313–21. doi:10.1016/j.psyneuen.2007.01.007
15. Muller DC, Giles GG, Manning JT, Hopper JL, English DR, Severi G. Second to
fourth digit ratio (2D:4D) and concentrations of circulating sex hormones in
adulthood. Reprod Biol Endocrinol (2011) 9:57. doi:10.1186/1477-7827-9-57
16. *Hampson E, Sankar JS. Re-examining the Manning hypothesis: androgen
receptor polymorphism and the 2D:4D digit ratio. Evol Hum Behav (2012)
33:557–61. doi:10.1016/j.evolhumbehav.2012.02.003
17. *Manning JT, Bundred PE, Newton DJ, Flanagan BF. The second to fourth digit
ratio and variation in the androgen receptor gene. Evol Hum Behav (2003)
24:399–405. doi:10.1016/S1090-5138(03)00052-7
18. Baculescu N. The role of androgen receptor activity mediated by the CAG repeat
polymorphism in the pathogenesis of PCOS. J Med Life (2013) 6:18–25.
19. Zitzmann M, Nieschlag E. The CAG repeat polymorphism within the androgen
receptor gene and maleness. Int J Androl (2003) 26:76–83. doi:10.1046/j.1365-
2605.2003.00393.x
20. Buchanan G, Yang M, Cheong A, Harris JM, Irvine RA, Lambert PF, et al. Struc-
tural and functional consequences of glutamine tract variation in the androgen
receptor. Hum Mol Genet (2004) 13:1677–92. doi:10.1093/hmg/ddh181
21. Beilin J, Ball EMA, Favaloro JM, Zajac JD. Effect of the androgen receptor CAG
repeat polymorphism on transcriptional activity: specificity in prostate and
non-prostate cell lines. J Mol Endocrinol (2000) 25:85–96. doi:10.1677/jme.0.
0250085
22. Chamberlain NL, Driver ED, Miesfeld RL. The length and location of CAG trinu-
cleotide repeats in the androgen receptor N-terminal domain affect transactiva-
tion function. Nucleic Acids Res (1994) 22:3181–6. doi:10.1093/nar/22.15.3181
23. Ding D, Xu L, Menon M, Reddy JPV, Barrack ER. Effect of a short CAG (gluta-
mine) repeat on human androgen receptor function. Prostate (2004) 58:23–32.
doi:10.1002/pros.10316
24. Callewaert L, Christiaens V, Haelens A, Verrijdt G, Verhoeven G, Claessens F.
Implications of a polyglutamine tract in the function of the human androgen
receptor. Biochem Biophys Res Commun (2003) 306:46–52. doi:10.1016/S0006-
291X(03)00902-1
25. Irvine RA, Ma H, Yu MC, Ross RK, Stallcup MR, Coetzee GA. Inhibition of
p160-mediated coactivation with increasing androgen receptor polyglutamine
length. Hum Mol Genet (2000) 9:267–74. doi:10.1093/hmg/9.2.267
26. Kazemi-Esfarjani P, Trifiro MA, Pinsky L. Evidence for a repressive function
of the long polyglutamine tract in the human androgen receptor: possible
*Entries marked by an asterisk appear in the meta-analysis.
www.frontiersin.org December 2013 | Volume 4 | Article 185 | 5
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hönekopp 2D:4D and CAG repeats in the AR gene
pathogenetic relevance for the (CAG)n-expanded neuronopathies. Hum Mol
Genet (1995) 4:523–7. doi:10.1093/hmg/4.4.523
27. *Butovskaya ML, Vasilyev VA, Lazebny OE, Burkova VN, Kulikov AM, Mabulla
A, et al. Aggression, digit ratio, and variation in the androgen receptor, serotonin
transporter and dopamine D4 receptor genes in African foragers: the Hadza.
Behav Genet (2012) 42:647–62. doi:10.1007/s10519-012-9533-2
28. *Zhang C, Dang J, Pei L, Guo M, Zhu H, Qu L, et al. Relationship of 2D:4D finger
ratio with androgen receptor CAG and GGN repeat polymorphism. Am J Hum
Biol (2013) 25:101–6. doi:10.1002/ajhb.22347
29. *Knickmeyer RC,Woolson S, Hamer RM, Konneker T, Gilmore JH. 2D:4D ratios
in the first 2 years of life: stability and relation to testosterone exposure and
sensitivity. Horm Behav (2011) 60:256–63. doi:10.1016/j.yhbeh.2011.05.009
30. *Loehlin JC, Medland SE, Martin NG. Is CAG sequence length in the andro-
gen receptor gene correlated with finger-length ratio? Pers Indiv Differ (2012)
52:224–7. doi:10.1016/j.paid.2011.09.009
31. *Hurd PL, Vaillancourt KL, Dinsdale NL. Aggression, digit ratio and variation in
androgen receptor and monoamine oxidase a genes in men. Behav Genet (2010)
41:543–56. doi:10.1007/s10519-010-9404-7
32. Schmidt FL, Oh IS, Hayes TL. Fixed- versus random-effects models in meta-
analysis: model properties and an empirical comparison of differences in results.
Br J Math Stat Psychol (2009) 62:97–128. doi:10.1348/000711007X255327
33. *Folland JP, McCauley TM, Phypers C, Hanson B, Mastana SS. Relation-
ship of 2D:4D finger ratio with muscle strength, testosterone, and andro-
gen receptor CAG repeat genotype. Am J Phys Anthropol (2012) 148:81–7.
doi:10.1002/ajpa.22044
34. *Mas M, Alonso C, Hernandez P, Fernandez M, Gutierrez P, Salido E, et al.
Androgen receptor CAG and GGN polymorphisms and 2D:4D finger ratio in
male to female transsexuals. J Sex Med (2009) 6(Suppl 5):419–20.
35. Cumming G. Understanding the New Statistics. Effect Sizes, Confidence Intervals,
and Meta-Analysis. New York: Routledge (2012).
36. Crabbe P, Bogaert V, de Bacquer D, Goemaere S, Zmierczak H, Kaufman JM.
Part of the interindividual variation in serum testosterone levels in healthy men
reflects differences in androgen sensitivity and feedback set point: contribution
of the androgen receptor polyglutamine tract polymorphism. J Clin Endocrinol
Metab (2007) 92:3604–10. doi:10.1210/jc.2007-0117
37. Huhtaniemi IT, Pye SR, Limer KL, Thomson W, O’Neill TW, Platt H, et al.
Increased estrogen rather than decreased androgen action is associated with
longer androgen receptor CAG repeats. J Clin Endocrinol Metab (2009)
94:277–84. doi:10.1210/jc.2008-0848
38. Davis-Dao CA, Tuazon ED, Sokol RZ, Cortessis VK. Male Infertility and varia-
tion in CAG repeat length in the androgen receptor gene: a meta-analysis. J Clin
Endocrinol Metab (2007) 92:4319–26. doi:10.1210/jc.2007-1110
39. Morales A. Androgen replacement therapy and prostate safety. Eur Urol (2002)
41:113–20. doi:10.1016/S0302-2838(01)00039-2
40. Randall VA. Physiology and pathophysiology of androgenetic Alopecia. Derma-
tol Ther (2008) 21:314–28. doi:10.1111/j.1529-8019.2008.00214.x
41. Wang R, Goodarzi MO, Xiong T, Wang D, Azziz R, Zhang H. Negative associa-
tion between androgen receptor gene CAG repeat polymorphism and polycys-
tic ovary syndrome? A systematic review and meta-analysis. Mol Hum Reprod
(2012) 18:498–509. doi:10.1093/molehr/gas024
42. Gu M, Dong X, Zhang X, Niu W. The CAG repeat polymorphism of andro-
gen receptor gene and prostate cancer: a meta-analysis. Mol Biol Rep (2012)
39:2615–24. doi:10.1007/s11033-011-1014-9
43. Zhuo FL, Xu W, Wang L, Wu Y, Xu ZL, Zhao JY. Androgen receptor gene
polymorphisms and risk for androgenetic alopecia: a meta-analysis. Clin Exp
Dermatol (2012) 37:104–11. doi:10.1111/j.1365-2230.2011.04186.x
44. Woodhouse LJ, Reisz-Porszasz S, Javanbakht M, Storer TW, Lee M, Zerounian
H, et al. Development of models to predict anabolic response to testosterone
administration in healthy young men. Am J Physiol Endocrinol Metab (2003)
284:E1009–17. doi:10.1152/ajpendo.00536.2002
45. Campbell BC, Gray PB, Eisenberg DTA, Ellison P, Sorenson MD. Androgen
receptor CAG repeats and body composition among Ariaal men. Int J Androl
(2007) 32:140–8. doi:10.1111/j.1365-2605.2007.00825.x
46. Guadalupe-Grau A, Rodríguez-González FG, Dorado C, Olmedillas H, Fuentes
T, Pérez-Gómez J. Androgen receptor gene polymorphisms lean mass and per-
formance in young men. Br J Sports Med (2011) 45:95–100. doi:10.1136/bjsm.
2009.060285
47. Lapauw B, Goemaere S, Crabbe P, Kaufman JM, Ruige JB. Is the effect of testos-
terone on body composition modulated by the androgen receptor gene CAG
repeat polymorphism in elderly men? Eur J Endocrinol (2007) 156:395–401.
doi:10.1530/EJE-06-0607
48. Voorhoeve PG, van Mechelen W, Uitterlinden AG, Delemarre-van de Waal HA,
Lamberts SWJ. Androgen receptor gene CAG repeat polymorphism in longitu-
dinal height and body composition in children and adolescents. Clin Endocrinol
(2011) 74:732–5. doi:10.1111/j.1365-2265.2011.03986.x
49. Walsh S, Zmuda JM, Cauley JA, Shea PR, Metter EJ, Hurley BF, et al. Androgen
receptor CAG repeat polymorphism is associated with fat-free mass in men.
J Appl Physiol (2005) 98:132–7. doi:10.1152/japplphysiol.00537.2004
50. Bennett M, Manning JT, Cook CJ, Kilduff LP. Digit ratio (2D:4D) and per-
formance in elite rugby players. J Sports Sci (2010) 28:1415–21. doi:10.1080/
02640414.2010.510143
51. Hönekopp J, Schuster M. A meta-analysis on 2D:4D and athletic prowess: sub-
stantial relationships but neither hand out-predicts the other. Pers Individ Dif
(2010) 48:4–10. doi:10.1016/j.paid.2009.08.009
52. Kilduff LP, Cook CJ, Manning JT. Digit ratio (2D:4D) and performance
in male surfers. J Strength Cond Res (2011) 25:3175–80. doi:10.1519/JSC.
0b013e318212de8e
53. Longman D, Stock JT, Wells JCK. Digit Ratio (2D:4D) and rowing ergometer
performance in males and females. Am J Phys Anthropol (2011) 144:337–41.
doi:10.1002/ajpa.21407
54. Voracek M, Reimer B, Dressler SG. Digit ratio (2D:4D) predicts sporting success
among female fencers independent from physical, experience, and personality
factors. Scand J Med Sci Sports (2010) 20:853–60. doi:10.1111/j.1600-0838.2009.
01031.x
55. Forstmeier W, Mueller JC, Kampenaers B. A polymorphism in the
oestrogen receptor gene explains covariance between digit ratio and mating
behaviour. Proc R Soc Lond B Biol Sci (2010) 277:3353–61. doi:10.1098/rspb.
2010.1007
56. Medland SE, Zayats T, Glaser B, Nyholt DR, Gordon SD, Wright MJ, et al. A vari-
ant in LIN28B is associated with 2D:4D finger-length ratio, a putative retro-
spective biomarker of prenatal testosterone exposure. Am J Hum Genet (2010)
86:519–25. doi:10.1016/j.ajhg.2010.02.017
57. Lawrance-Owen AJ, Bargary G, Bosten JM, Goodbourn PT, Hogg RE, Mollon
JD. Genetic association suggests that SMOC1 mediates between prenatal sex
hormones and digit ratio. Hum Genet (2013) 132:415–21. doi:10.1007/s00439-
012-1259-y
Conflict of Interest Statement: The author declares that the research was conducted
in the absence of any commercial or financial relationships that could be construed
as a potential conflict of interest.
Received: 05 September 2013; accepted: 13 November 2013; published online: 05
December 2013.
Citation: Hönekopp J (2013) No evidence that 2D:4D is related to the num-
ber of CAG repeats in the androgen receptor gene. Front. Endocrinol. 4:185. doi:
10.3389/fendo.2013.00185
This article was submitted to Pediatric Endocrinology, a section of the journal Frontiers
in Endocrinology.
Copyright © 2013 Hönekopp. This is an open-access article distributed under the terms
of the Creative Commons Attribution License (CC BY). The use, distribution or repro-
duction in other forums is permitted, provided the original author(s) or licensor are
credited and that the original publication in this journal is cited, in accordance with
accepted academic practice. No use, distribution or reproduction is permitted which
does not comply with these terms.
Frontiers in Endocrinology | Pediatric Endocrinology December 2013 | Volume 4 | Article 185 | 6
